Literature DB >> 7538563

Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.

G Nikkhah1, M G Cunningham, M A Cenci, R D McKay, A Björklund.   

Abstract

Reconstruction of the nigrostriatal pathway by long axon growth derived from dopamine-rich ventral mesencephalic (VM) transplants grafted into the substantia nigra may enhance their functional integration as compared to VM grafts implanted ectopically into the striatum. Here we report on a novel approach by which fetal VM grafts are implanted unilaterally into the substantia nigra (SN) of 6-hydroxydopamine (6-OHDA)-lesioned neonatal pups at postnatal day 3 (P3) using a microtransplantation technique. The results demonstrate that homotopically placed dopaminergic neurons survive and integrate well into the previously 6-OHDA-lesioned neonatal SN region. Moreover, the tyrosine hydroxylase (TH)-positive neurons extended axons rostrally along the white matter tract of the internal capsule closely following the course of the original nigrostriatal pathway. The graft reestablished a TH-positive axon terminal network in the ipsilateral caudate-putamen, with the highest density in the medial and central parts. Retrograde labeling with Fluoro-Gold from the host striatum demonstrated that most of the transplant neurons giving rise to the graft-derived fiber outgrowth were TH-positive, but revealed also a small proportion of projecting neurons which were TH-negative. Amphetamine-induced striatal Fos expression was normalized in the caudate-putamen ipsilateral to the intranigral VM grafts, showing hyperexpression in some areas of the striatum, and the apomorphine-induced Fos expression seen in the 6-OHDA-lesioned animals was completely reversed on the grafted side. These findings indicate that the graft-derived dopaminergic reinnervation of the striatum is functional. The microtransplantation strategy may provide new avenues for the exploration of morphological and functional integration of fetal dopamine neurons in the nigrostriatal system and give new insights into the mechanisms controlling long-distance axon growth in the brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538563      PMCID: PMC6578221     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  14 in total

1.  Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance.

Authors:  G Nikkhah; G Falkenstein; C Rosenthal
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

Authors:  Marine Hovakimyan; Stefan Jean-Pierre Haas; Oliver Schmitt; Bernd Gerber; Andreas Wree; Christian Andressen
Journal:  J Anat       Date:  2006-12       Impact factor: 2.610

Review 3.  Stem cell therapy for neurological disorders: A focus on aging.

Authors:  Hung Nguyen; Sydney Zarriello; Alexandreya Coats; Cannon Nelson; Chase Kingsbury; Anna Gorsky; Mira Rajani; Elliot G Neal; Cesar V Borlongan
Journal:  Neurobiol Dis       Date:  2018-09-13       Impact factor: 5.996

4.  Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants.

Authors:  I Mendez; D Sadi; M Hong
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

5.  Delivery of chemotropic proteins and improvement of dopaminergic neuron outgrowth through a thixotropic hybrid nano-gel.

Authors:  Elisa Tamariz; Andrew C A Wan; Y Shona Pek; Magda Giordano; Genoveva Hernández-Padrón; Alfredo Varela-Echavarría; Iván Velasco; Víctor M Castaño
Journal:  J Mater Sci Mater Med       Date:  2011-07-09       Impact factor: 3.896

6.  Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Authors:  Ming Li; Shi-Zhong Zhang; Yan-Wu Guo; Ying-qian Cai; Zhong-jie Yan; Zhihao Zou; Xiao-Dan Jiang; Yi-Quan Ke; Xu-ying He; Zeng-liang Jin; Guo-hui Lu; Dao-qing Su
Journal:  Neurochem Res       Date:  2010-07-24       Impact factor: 3.996

Review 7.  Developments in intracerebral stem cell grafts.

Authors:  Stephanny Reyes; Naoki Tajiri; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2015-03-05       Impact factor: 4.618

8.  Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.

Authors:  C Zhang; Y Jin; K S Ziemba; A M Fletcher; B Ghosh; E Truit; D M Yurek; G M Smith
Journal:  Exp Neurol       Date:  2013-10-04       Impact factor: 5.330

9.  Extrastriatal dopaminergic circuits of the Basal Ganglia.

Authors:  Karen S Rommelfanger; Thomas Wichmann
Journal:  Front Neuroanat       Date:  2010-10-27       Impact factor: 3.856

10.  Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.

Authors:  Laura A Struzyna; Kevin D Browne; Zachary D Brodnik; Justin C Burrell; James P Harris; H Isaac Chen; John A Wolf; Kate V Panzer; James Lim; John E Duda; Rodrigo A España; D Kacy Cullen
Journal:  J Tissue Eng Regen Med       Date:  2018-06-03       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.